Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy

PURPOSE: To examine the efficacy of rituximab as a monotherapy or in combination therapy for the treatment of patients with non-paraneoplastic autoimmune retinopathy. METHODS: Twelve eyes of six patients with non-paraneoplastic autoimmune retinopathy who were treated with rituximab and had at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Maleki, Arash, Lamba, Neerav, Ma, Lina, Lee, Stacey, Schmidt, Alexander, Foster, C Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322851/
https://www.ncbi.nlm.nih.gov/pubmed/28255228
http://dx.doi.org/10.2147/OPTH.S120162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322851/
https://www.ncbi.nlm.nih.gov/pubmed/28255228
http://dx.doi.org/10.2147/OPTH.S120162

Ejemplares similares